Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Why Emergent BioSolutions Crashed Today


Emergent BioSolutions (NYSE: EBS) was a dog of a stock Thursday, plummeting to close down by over 13%. This followed news that the company apparently erred in the production process of Johnson & Johnson's (NYSE: JNJ) recently authorized coronavirus vaccine.

Johnson & Johnson claimed that one batch of the vaccine manufactured at Emergent's Baltimore facility did not meet its quality standards, and thus could not be used. It did not specify the number of affected doses.

Image source: Getty Images.

Continue reading


Source Fool.com

Like: 0
EBS
Share

Comments